ALX Oncology Holdings
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $170,278,000.
Profit Margin
| 2018 | 2.06M | -13.73M | -664.3% |
|---|---|---|---|
| 2019 | 4.79M | -19.24M | -401.23% |
| 2020 | 1.18M | -45.74M | -3869.71% |
| 2021 | 0 | -83.46M | |
| 2022 | 0 | -123.48M | |
| 2023 | 0 | -160.80M |
ALXO Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 0 | 1.18M | 4.79M | 2.06M |
Cost of revenue | 836K | 1.46M | 736K | 1.07M | 4.36M | 1.88M |
Gross profit | -836K | -1.46M | -736K | 107K | 436K | 187K |
Operating exp. | ||||||
Research and development | 141.79M | 98.4M | 60.17M | 28.96M | 16.30M | 11.27M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 170.27M | 127.43M | 83.55M | 43.77M | 19.61M | 13.87M |
Operating income | -170.27M | -127.43M | -83.55M | -43.66M | -19.18M | -13.68M |
Other income (expenses), net | 9.47M | 4.01M | 71K | -1.83M | -26K | -2K |
Income before tax | -160.80M | -123.41M | -83.48M | -45.49M | -19.20M | -13.68M |
Income tax expense | 0 | 64K | -21K | 241K | 34K | 45K |
Net income | -160.80M | -123.48M | -83.46M | -45.74M | -19.24M | -13.73M |
Earnings per share | ||||||
Basic EPS | -3.74 | -3.03 | -2.07 | -1.15 | -0.53 | -0.63 |
Diluted EPS | -3.74 | -3.03 | -2.07 | -1.15 | -0.53 | -0.63 |
| Data source | Data source | Data source | Data source |